Brand protection and anti-counterfeiting solutions in the pharmaceutical space have evolved rapidly in India in response to the increased risk of counter­feit medications, with regulators making changes to laws and processes to ensure patient safety from counterfeit medications. Advanced solutions also include serializa­tion, track-and-trace systems, holographic security labels, RFID tagging, blockchain-enabled supply chain visibility, and AI-enabled authentication systems. These solutions not only support pharmaceutical companies from revenue loss, but they also maintain consumer trust while protecting brand integrity.

The market for pharmaceutical anti-counterfeiting solu­tions in India has experienced substantial growth, with the market size estimated in the billions of dollars, reflecting its dominant position in the world’s largest generic drug manufacturing environment. Growth is being generated through government regulation requiring barcoding of export drugs, consumer awareness, and the use of digital monitoring in supply chains. The industry is growing at a double-digit CAGR on the back of increased investment from domestic suppliers and international technology suppliers. The economic contributions of this sector are significant; secure supply chains help to limit illicit trade, uphold tax revenues, and build faith in Indian pharmaceutical exports. Companies are able to maintain profitability and...